Hypomethylation and hypermethylation of DNA in Wilms tumors
暂无分享,去创建一个
P. Laird | M. Widschwendter | M. Ehrlich | T. Long | E. Fiala | G. Liang | Mimi C. Yu | M. Chintagumpala | G. Tomlinson | J. Dome | D. Parham | O. Sohn | K. Malik | G. Jiang | M. Champagne | B. Youn | M. Yu
[1] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[2] Kenichi Harada,et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines , 2002, Oncogene.
[3] Andrew P Feinberg,et al. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. , 2002, Genome research.
[4] Wendy Dean,et al. Dynamic reprogramming of DNA methylation in the early mouse embryo. , 2002, Developmental biology.
[5] W. Lau,et al. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. , 2001, The American journal of pathology.
[6] A. Protopopov,et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. Hanash,et al. Unexpected effects of a heterozygous dnmt1 null mutation on age-dependent DNA hypomethylation and autoimmunity. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] O. Haas,et al. Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours. , 2001, Cancer letters.
[9] J. Minna,et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.
[10] A. Thern,et al. Genomic structure, expression, and chromosome mapping of the mouse homologue for the WSL-1 (DR3, Apo3, TRAMP, LARD, TR3, TNFRSF12) gene , 2001, Immunogenetics.
[11] L. Kluijtmans,et al. The human and mouse methylenetetrahydrofolate reductase (MTHFR) genes: genomic organization, mRNA structure and linkage to the CLCN6 gene. , 2000, Gene.
[12] D. Demetrick,et al. Decreased expression of the INK4 family of cyclin‐dependent kinase inhibitors in Wilms tumor , 2000, Genes, chromosomes & cancer.
[13] M. Toyota,et al. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. , 2000, Cancer research.
[14] M. Ehrlich,et al. DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients , 2000, Cytogenetic and Genome Research.
[15] K. Moorwood,et al. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor. , 2000, Cancer research.
[16] P. Laird,et al. MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.
[17] W. Reik,et al. Active demethylation of the paternal genome in the mouse zygote , 2000, Current Biology.
[18] Philip H. Ramsey. Nonparametric Statistical Methods , 1974, Technometrics.
[19] M. Ehrlich. DNA alterations in cancer : genetic and epigenetic changes , 2000 .
[20] P. Laird,et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.
[21] M. Ehrlich,et al. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.
[22] M. Ehrlich,et al. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.
[23] S. Baylin,et al. Aging and DNA methylation in colorectal mucosa and cancer. , 1998, Cancer research.
[24] S. Baylin,et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas , 1998, International journal of cancer.
[25] V. Valentine,et al. Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma. , 1998, Genomics.
[26] Y. Hosoya,et al. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[27] Mimi C. Yu,et al. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. , 1997, British Journal of Cancer.
[28] S. Baylin,et al. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] L. Frappart,et al. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p , 1994, Journal of cellular biochemistry.
[30] A. Razin,et al. DNA methylation from embryo to adult. , 1994, Progress in nucleic acid research and molecular biology.
[31] M. Lipinski,et al. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in epstein‐barr‐virus‐positive nasopharyngeal carcinoma cells , 1992, International journal of cancer.
[32] M. Ehrlich,et al. Hypermethylation of human DNA sequences in embryonal carcinoma cells and somatic tissues but not in sperm. , 1987, Nucleic acids research.
[33] M. Frommer,et al. CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.
[34] V. Chapman,et al. Cell lineage-specific undermethylation of mouse repetitive DNA , 1984, Nature.
[35] M. Ehrlich,et al. The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.
[36] A. Feinberg,et al. Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.
[37] M. Ehrlich,et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. , 1982, Nucleic acids research.